Showing results (371-380 of 457) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|February 22, 2014
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trialRobert J Motzer, Camillo Porta, Nicholas J Vogelzang, et al.
The New England Journal of Medicine|August 17, 2012
Increased survival with enzalutamide in prostate cancer after chemotherapyHoward I Scher, Karim Fizazi, Fred Saad, et al.
Urologic Oncology|July 15, 2020
Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survivalCamilla M Grunewald, Alina Henn, Matthew D Galsky, et al.
European Journal of Neurology|June 10, 2014
Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor useS-Y Lin, S-C Tang, L-K Tsai, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2022
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302Brooke E Wilson, Andrew J Armstrong, Johann de Bono, et al.
European Urology|September 15, 2023
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before MaintenanceSrikala S Sridhar, Thomas Powles, Miguel Á Climent Durán, et al.
Translational Oncology|November 15, 2020
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncologyShaham Beg, Rohan Bareja, Kentaro Ohara, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinomaGuru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)A Bamias, K Tzannis, L C Harshman, et al.
Cell Reports. Medicine|February 14, 2023
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancerBrittiny Dhital, Sandra Santasusagna, Perumalraja Kirthika, et al.
Pageof 46